A breast cancer medicine can cure the _ treatment of gastric carcinoma
A latest research in U.S.A. reveals, treat the target of breast cancer to the medicine " one hertz of spit of fland of match " There is a good result too in dealing with gastric carcinoma. In learn, say at the annual meeting on that city hold the intersection of U.S.A. and clinical tumour, Orlando of American, researcher, this discovery becomes " Should carry on another illustration of individualized treatment according to the genetic characteristic of disease " .
According to the news that the annual meeting is released, researchers find in a test that carries on to nearly 600 people, it is accepted that standard chemotherapy is united " The hertz of spit of fland of match " Later period the intersection of gastric carcinoma and patient that treat, reach 13.8 month life cycle on average, than accept standard life cycle large 2.7 months on average, patient of control group, of chemotherapy only. It is reported, because assess and already reveal " one hertz of spit of fland of match " in middle period of this test There is obvious curative effect on gastric carcinoma in later period, and there is no unexpected side effect, so has tested and has already been over ahead of time.
" one hertz of spit of fland of match " It is a target which the Luo of Switzerland Company researches and develops to the medicine, it is a source antibody of a kind of person, can block a kind of function which is called HER2 protein, and this protein is protein that produced that a kind of potential oncogene encodes. Before this, this medicine has already been listed on a plurality of countries and regions, has got permission to be used for treating breast cancer.
Researchers explain, further discover, gastric carcinoma patients are basically all HER2 positive patients in later period when the therapeutic effect is comparatively obvious, that is to say, sanction " one hertz of spit of fland of match " before this The mechanism of treating breast cancer may be suitable for the patient whose stomach presents this kind of tumour too. This discovery proves, do not limited to traditional tumour is divided but the particular biological mark based on that the genetic characteristic of disease is looked for to treat tumour is treated at the same time, namely it is individualized to offer to patient and treat, should become the new research trend.
At present, as to the thing that very limited that the treatment of the gastric carcinoma patient is chosen in later period, and the result is not very ideal. Statistics reveal, over 800,000 people die of later period gastric carcinoma every year in the whole world at present.
|
0 comments:
Post a Comment